ATE470456T1 - Bifunktionale tridentate pyrazolyl-enthaltende liganden für re-, tc- und mn- tricarbonyl- komplexe - Google Patents

Bifunktionale tridentate pyrazolyl-enthaltende liganden für re-, tc- und mn- tricarbonyl- komplexe

Info

Publication number
ATE470456T1
ATE470456T1 AT04759566T AT04759566T ATE470456T1 AT E470456 T1 ATE470456 T1 AT E470456T1 AT 04759566 T AT04759566 T AT 04759566T AT 04759566 T AT04759566 T AT 04759566T AT E470456 T1 ATE470456 T1 AT E470456T1
Authority
AT
Austria
Prior art keywords
containing ligands
aryl
alkyl
tricarbonyl complexes
tridentate
Prior art date
Application number
AT04759566T
Other languages
English (en)
Inventor
Isabel Santos
Correia Joao Galamba
Paulo Antonio Rocha
Susana Alves
Rute Vitor
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP03078217A external-priority patent/EP1529537A1/de
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Application granted granted Critical
Publication of ATE470456T1 publication Critical patent/ATE470456T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04759566T 2003-04-15 2004-04-15 Bifunktionale tridentate pyrazolyl-enthaltende liganden für re-, tc- und mn- tricarbonyl- komplexe ATE470456T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03076106 2003-04-15
EP03078217A EP1529537A1 (de) 2003-10-10 2003-10-10 Bifunktionelle dreizähnige Pyrazolyl-enthaltende Liganden für re, tc und mn tricarbonyl Komplexe
PCT/US2004/011685 WO2004091669A1 (en) 2003-04-15 2004-04-15 Bifunctional tridentate pyrazolyl containing ligands for re and tc tricarbonyl complexes

Publications (1)

Publication Number Publication Date
ATE470456T1 true ATE470456T1 (de) 2010-06-15

Family

ID=33300977

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04759566T ATE470456T1 (de) 2003-04-15 2004-04-15 Bifunktionale tridentate pyrazolyl-enthaltende liganden für re-, tc- und mn- tricarbonyl- komplexe

Country Status (11)

Country Link
EP (1) EP1644050B1 (de)
JP (1) JP2007525452A (de)
KR (1) KR20050119694A (de)
CN (1) CN101928327A (de)
AT (1) ATE470456T1 (de)
AU (1) AU2004229568A1 (de)
CA (1) CA2522326C (de)
DE (1) DE602004027631D1 (de)
ES (1) ES2346974T3 (de)
NO (1) NO334346B1 (de)
WO (1) WO2004091669A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0716368A2 (pt) * 2006-08-29 2013-10-01 Molecular Insight Pharm Inc porÇÕes de radioimageamento acopladas a porÇÕes de ligaÇço Á peptidase para imageamento de tecidos e àrgços que expressam peptidases
US20080193381A1 (en) * 2006-11-08 2008-08-14 Molecular Insight Pharmaceuticals, Inc. Heterodimers of glutamic acid
GB0623482D0 (en) 2006-11-24 2007-01-03 Mallinckrodt Inc Technetium-99m (l) tricarbonyl complexes with tridentate chelators for myocardium imaging
CN118725025A (zh) * 2024-06-04 2024-10-01 厦门稀土材料研究所 用于177Lu标记的三齿类酰胺酸型双功能螯合剂及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5855867A (en) * 1995-03-29 1999-01-05 The Curators Of The University Of Missouri Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same
EP0879606A1 (de) 1997-04-25 1998-11-25 Paul Scherrer Institut Verfahren zur Herstellung von facial Metall Tricarbonyl Verbindungen und ihre Anwendung zur Markierung von Biosubstraten
US6344178B1 (en) 1997-04-25 2002-02-05 Mallinckrodt Inc. Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates
DE19860289C2 (de) 1998-12-21 2003-11-13 Schering Ag Neue Chelatoren sowie deren Tricarbonyl-Komplexe mit Technetium und Rhenium
WO2000050086A1 (en) 1999-02-24 2000-08-31 Mallinckrodt Inc. Molecules for the treatment and diagnosis of tumors
AU6488900A (en) 1999-06-29 2001-01-31 Mallinckrodt, Inc. Group (vii) transition-metal complexes with multidentate aminopolycarboxylate ligands and a kit for producing them

Also Published As

Publication number Publication date
EP1644050A1 (de) 2006-04-12
CA2522326C (en) 2012-09-18
KR20050119694A (ko) 2005-12-21
CN101928327A (zh) 2010-12-29
NO20055334L (no) 2005-11-11
ES2346974T3 (es) 2010-10-22
EP1644050B1 (de) 2010-06-09
NO334346B1 (no) 2014-02-10
DE602004027631D1 (de) 2010-07-22
AU2004229568A1 (en) 2004-10-28
WO2004091669A1 (en) 2004-10-28
JP2007525452A (ja) 2007-09-06
CA2522326A1 (en) 2004-10-28

Similar Documents

Publication Publication Date Title
MXPA05010652A (es) Pirazoles sustituidos.
AR040480A1 (es) Uso de compuestos de complejos metalicos como catalizadores de oxidacion
BR0213140A (pt) Fungicidas de pirazol-pirimidina
DE602004029983D1 (de) Verbesserte radiometall-komplex-zusammensetzungen
ATE525753T1 (de) Binukleärer metallkomplex, metallkomplexfarbstoff,photoelektrischer transducer und photochemische batterie
EP1826196A3 (de) Vinylether-Verbindungen
TW200503993A (en) Arylalkylcarbamate derivatives, their preparation and their application in therapy
Sutradhar et al. Coordination versatility of 1, 5-bis (salicylidene) carbohydrazide in Ni (II) complexes
ATE381554T1 (de) Aroylfurane und aroylthiophene, die sich für die behandlung von krebs eignen
IL159534A0 (en) Method for the preparation of selectively-substituted corroles and new substituted corroles
RU2007148231A (ru) Способ синтеза органических соединений
ATE470456T1 (de) Bifunktionale tridentate pyrazolyl-enthaltende liganden für re-, tc- und mn- tricarbonyl- komplexe
MXPA05010651A (es) Compuestos de pirazol.
EP1706452A4 (de) Aromatische triamid-lanthanid-komplexe
TW200609326A (en) Organometallic compound and organic electroluminescent device including the same
ATE402720T1 (de) Konjugate von tc komplexen und zielgerichtete einheiten und ihre verwendung in nmr-diagnostik
MY127738A (en) Tridentate ligands and relative complexes with transition metals
DE602004002114D1 (de) Substituierte ferrocenyldiphosphinligande für homogene hydrogenieringskatalysatoren
SE0303090D0 (sv) Novel compounds
TW200602689A (en) Colorant-containg curable composition, color filter and method for producing the same
DE60122706D1 (de) Tc and re karbonylkomplexen zur herstellung von pertechnaten und perrhenaten
JP2003327590A5 (de)
ATE443070T1 (de) Metallkomplexe mit vitamin b12 als ligand
EP1758976A4 (de) Bleich- und waschmittel mit wenig aufwendig aus tetra-aza-macrocyclischen liganden synthetisiertem mangankomplex
WO2003072586A3 (en) Methods of producing phosphitylated compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties